0001179110-22-001381.txt : 20220217 0001179110-22-001381.hdr.sgml : 20220217 20220217171812 ACCESSION NUMBER: 0001179110-22-001381 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sagartz John E CENTRAL INDEX KEY: 0001746201 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23357 FILM NUMBER: 22649411 MAIL ADDRESS: STREET 1: 19 WORTHINGTON ACCESS DRIVE CITY: MARYLAND HEIGHTS STATE: MO ZIP: 63043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inotiv, Inc. CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 FORMER COMPANY: FORMER CONFORMED NAME: BIOANALYTICAL SYSTEMS INC DATE OF NAME CHANGE: 19970918 4 1 edgar.xml FORM 4 - X0306 4 2022-02-15 0 0000720154 Inotiv, Inc. NOTV 0001746201 Sagartz John E C/O INOTIV, INC. 2701 KENT AVENUE WEST LAFAYETTE IN 47906-1382 1 1 0 0 Chief Strategy Officer Common Shares 2022-02-15 4 A 0 30000 0 A 678524 D Common Shares 2022-02-17 4 P 0 2506 19.9516 A 681030 D Represents an award of restricted stock units that may be settled only by delivery of an equal number of common shares. The units are subject to forfeiture and vest in equal installments of 6,000 shares on each of the first five anniversaries of the grant date, subject to continued employment, and in certain circumstances upon or following a change in control. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.9111 to $19.96, inclusive. The reporting person undertakes to provide to Inotiv, Inc., any security holder of Inotiv, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Beth Taylor, attorney-in-fact for John E. Sagartz 2022-02-17